ArticleAdvances in pharmacological and pharmaceutical sciences2025

Safety, Tolerability, and Pharmacokinetics of NorUrsodeoxycholic Acid (Shilpa Medicare Limited, India) in Healthy Adults: Results From a Phase I Open-Label Dose-Escalation Study.

Veerendra Kumar Panuganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.